V. Brouste

发表

Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity

J. Blay, F. Collin, F. Chibon, 2010, Nature Medicine.

Tissue microarray cytometry reveals positive impact of homeodomain interacting protein kinase 2 in colon cancer survival irrespective of p53 function.

V. Brouste, I. Soubeyran, I. Mahouche, 2011, The American journal of pathology.

Variables with time-varying effects and the Cox model: Some statistical concepts illustrated with a prognostic factor study in breast cancer

Gaëtan MacGrogan, Simone Mathoulin-Pélissier, Carine A Bellera, 2010, BMC medical research methodology.

High inter-observer agreement in immunohistochemical evaluation of HER-2/neu expression in breast cancer: a multicentre GEFPICS study.

Anne Vincent-Salomon, Magali Lacroix-Triki, Marie-Christine Mathieu, 2006, European journal of cancer.

Prognostic factors of early distant recurrence in hormone receptor‐positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy

V. Brouste, G. MacGrogan, S. Mathoulin-Pélissier, 2007, Cancer.

All atypia diagnosed at stereotactic vacuum-assisted breast biopsy do not need surgical excision

V. Brouste, G. MacGrogan, I. Mascarel, 2011, Modern Pathology.

Epithelial atypia: a marker risk of concomitant or subsequent breast carcinoma?

A. Vincent-Salomon, V. Brouste, I. de Mascarel, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Determination of ERCC2 Lys751Gln and GSTP1 Ile105Val gene polymorphisms in colorectal cancer patients: relationships with treatment outcome.

V. Brouste, S. Mathoulin-Pélissier, I. Soubeyran, 2007, Pharmacogenomics.

Pegylated liposomal doxorubicin and cyclophosphamide in early recurrent ovarian carcinoma: phase I dose-finding study

V. Brouste, S. Mathoulin-Pélissier, A. Floquet, 2013, Cancer Chemotherapy and Pharmacology.

Survival after resection plus intra-operative radiofrequency ablation (IRFA) to treat colorectal liver metastases (CLM): Results of an international collaborative study.

V. Brouste, S. Mathoulin-Pélissier, M. D'Angelica, 2013 .

Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation.

J. Blay, S. Salas, V. Brouste, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors

F. Collin, F. Chibon, P. Lagarde, 2010, Genes, chromosomes & cancer.

High frequency of β-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management

J. Blay, F. Collin, R. Sciot, 2010, British Journal of Cancer.

Single-Session Radiofrequency Ablation of Bilateral Lung Metastases

V. Brouste, A. Avril, S. Ferron, 2012, CardioVascular and Interventional Radiology.

Imaging features of sporadic breast cancer in women under 40 years old: 97 cases

V. Brouste, G. MacGrogan, H. Bonnefoi, 2013, European Radiology.

Docetaxel rechallenge after a first response in non-resistant metastatic breast cancer: significant activity with manageable toxicity

V. Brouste, G. MacGrogan, M. Toulmonde, 2012, Breast Cancer Research and Treatment.

Helical tomotherapy of spinal chordomas: French Multicentric, retrospective study of a cohort of 30 cases

L. Gras, V. Brouste, C. Zacharatou, 2017, Radiation oncology.

Sarcoma Lung Metastases Treated with Percutaneous Radiofrequency Ablation: Results from 29 Patients

V. Brouste, B. Bui, A. Italiano, 2011, Annals of Surgical Oncology.

Pulmonary Thermal Ablation Enables Long Chemotherapy-Free Survival in Metastatic Colorectal Cancer Patients

X. Buy, V. Brouste, Y. Bécouarn, 2018, CardioVascular and Interventional Radiology.

A single-center study on total mastectomy versus skin-sparing mastectomy in case of pure ductal carcinoma in situ of the breast.

V. Brouste, G. MacGrogan, S. Mathoulin-Pélissier, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Progress in Survival Outcomes in Patients with Advanced Ovarian Cancer Treated by Neo-Adjuvant Platinum/Taxane-Based Chemotherapy and Late Interval Debulking Surgery

F. Guyon, V. Brouste, A. Floquet, 2014, Annals of Surgical Oncology.

Optimal timing of interval debulking surgery in advanced ovarian cancer: yet to be defined?

F. Guyon, V. Brouste, A. Floquet, 2011, European journal of obstetrics, gynecology, and reproductive biology.

Vertebroplasty in patients with prostate cancer raises skeletal morbidity characterized by bone loss

X. Buy, V. Brouste, N. Houédé, 2020 .

Hepatotoxicities Induced by Neoadjuvant Chemotherapy in Colorectal Cancer Liver Metastases: Distinguishing the True From the False

V. Brouste, B. le Bail, Y. Bécouarn, 2019, Clinical Medicine Insights. Oncology.

Cytoreductive Surgery of Colorectal Peritoneal Metastases: Outcomes after Complete Cytoreductive Surgery and Systemic Chemotherapy Only

V. Brouste, Y. Bécouarn, S. Evrard, 2015, PloS one.

Comprehensive prognostic analysis in breast cancer integrating clinical, tumoral, micro-environmental and immunohistochemical criteria

Gaëtan MacGrogan, F. Chibon, V. Brouste, 2015, SpringerPlus.

Conspicuity and imaging features of breast cancers on digital breast tomosynthesis according to molecular profile

V. Brouste, F. Chamming's, B. Mesurolle, 2021 .

[Prognostic impact of tumour volume and lymph node involvement in intermediate stage T1b1 to T2b cancer of the uterine cervix].

F. Guyon, V. Brouste, A. Floquet, 2009, Bulletin du cancer.

Lymph Node Involvement in Epithelial Ovarian Cancer: Sites and Risk Factors in a Series of 355 Patients

F. Guyon, V. Brouste, G. MacGrogan, 2009, International Journal of Gynecologic Cancer.

Lung Tumors Treated With Percutaneous Radiofrequency Ablation: Computed Tomography Imaging Follow-Up

A. Ravaud, V. Brouste, T. Baère, 2011, CardioVascular and Interventional Radiology.

Soft tissue sarcomas of the trunk wall (STS-TW): a study of 343 patients from the French Sarcoma Group (FSG) database.

F. Collin, S. Salas, V. Brouste, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

An immunological signature to predict outcome in patients with triple-negative breast cancer with residual disease after neoadjuvant chemotherapy

É. Darbo, V. Brouste, G. MacGrogan, 2022, ESMO open.

High-dose pre-operative helical tomotherapy (54 Gy) for retroperitoneal liposarcoma

V. Brouste, A. Italiano, G. Kantor, 2012, Radiation Oncology.

Imaging findings of triple-negative breast cancers

V. Brouste, G. MacGrogan, S. Mathoulin-Pélissier, 2012 .

Expression of Gastrin-Releasing Peptide Receptor in Breast Cancer and Its Association with Pathologic, Biologic, and Clinical Parameters: A Study of 1,432 Primary Tumors

E. Hindié, V. Brouste, G. MacGrogan, 2017, The Journal of Nuclear Medicine.

Reply to Y. Nishida et al

J. Blay, V. Brouste, B. Bui, 2012 .

First-Line Capecitabine Monotherapy for Slowly Progressing Metastatic Breast Cancer: Do We Need Aggressive Treatment?

V. Brouste, L. Mauriac, A. Floquet, 2009, Oncology.

Breast hamartoma: reassessment of an under‐recognised breast lesion

V. Brouste, G. MacGrogan, V. Vélasco, 2021, Histopathology.

Prognostic value of Mib1 in a tissue microarray of 855 invasive breast carcinomas

V. Brouste, G. MacGrogan, L. Mauriac, 2006 .

Time-varying coefficients in a multivariate frailty model: Application to breast cancer recurrences of several types and death

V. Brouste, G. MacGrogan, S. Mathoulin-Pélissier, 2015, Lifetime Data Analysis.

Retroperitoneal sarcomas: patterns of care in advanced stages, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group.

J. Blay, V. Brouste, P. Terrier, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Soft tissue masses with myxoid stroma: Can conventional magnetic resonance imaging differentiate benign from malignant tumors?

X. Buy, V. Brouste, J. Coindre, 2016, European journal of radiology.

PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomas.

V. Brouste, G. MacGrogan, N. Sevenet, 2022, Cancer genetics.

Prognostic Value of PLAGL1-Specific CpG Site Methylation in Soft-Tissue Sarcomas

F. Chibon, P. Lagarde, V. Brouste, 2013, PloS one.

High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome

V. Brouste, N. Sevenet, B. Gilbert-Dussardier, 2013, Journal of Medical Genetics.

Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group.

J. Blay, V. Brouste, P. Terrier, 2014 .

Comprehensive analysis of PTEN status in breast carcinomas

V. Brouste, G. MacGrogan, N. Sevenet, 2013, International journal of cancer.

The risk of postoperative complications and functional impairment after multimodality treatment for limb and trunk wall soft-tissue sarcoma: Long term results from a monocentric series.

V. Brouste, M. Toulmonde, A. Italiano, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The introduction of early patient rehabilitation in surgery of soft tissue sarcoma and its impact on post-operative outcome.

V. Brouste, A. Italiano, M. Kind, 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Idylla EGFR assay on extracted DNA: advantages, limits and place in molecular screening according to the latest guidelines for non-small-cell lung cancer (NSCLC) patients

V. Brouste, I. Soubeyran, C. Primois, 2022, Journal of clinical pathology.

An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis

V. Brouste, I. de Mascarel, G. MacGrogan, 2012, BMC Medical Genomics.

High-dose pre-operative helical tomotherapy (54 Gy) for retroperitoneal liposarcoma

V. Brouste, A. Italiano, G. Kantor, 2012, Radiation oncology.

SOX10, GATA3, GCDFP15, Androgen Receptor, and Mammaglobin for the Differential Diagnosis Between Triple-negative Breast Cancer and TTF1-negative Lung Adenocarcinoma

V. Brouste, G. MacGrogan, H. Bégueret, 2019, The American journal of surgical pathology.

Soft-Tissue Sarcomas: Assessment of MRI Features Correlating with Histologic Grade and Patient Outcome.

X. Buy, V. Brouste, A. Italiano, 2019, Radiology.

[Hodgkin's disease and breast cancer: for which patients is there an association? A series from Institut Bergonié].

V. Brouste, P. Richaud, E. Bussières, 2012, Gynecologie, obstetrique & fertilite.

Retrospective review of thoracic neural damage during lung ablation – what the interventional radiologist needs to know about neural thoracic anatomy

M. Montaudon, V. Brouste, F. Cornelis, 2013, CardioVascular and Interventional Radiology.

Neoadjuvant endocrine treatment in breast cancer: analysis of daily practice in large cancer center to facilitate decision making.

V. Brouste, G. MacGrogan, L. Mauriac, 2014, American journal of surgery.

Population-Based Study of Peritumoral Lymphovascular Invasion and Outcome Among Patients With Operable Breast Cancer

V. Brouste, G. MacGrogan, L. Mauriac, 2010 .

D2-40 in breast cancer: should we detect more vascular emboli?

V. Brouste, G. MacGrogan, S. Mathoulin-Pélissier, 2009, Modern Pathology.

Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapy

V. Brouste, G. MacGrogan, H. Bonnefoi, 2019, Breast Cancer Research and Treatment.

Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group.

J. Blay, V. Brouste, P. Terrier, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Is it useful to detect lymphovascular invasion in lymph node‐positive patients with primary operable breast cancer?

V. Brouste, I. de Mascarel, G. MacGrogan, 2010, Cancer.

First-line chemotherapy for metastatic breast cancer in patients ≥75 years: a retrospective single-centre analysis.

V. Brouste, L. Mauriac, M. Durand, 2011, Critical reviews in oncology/hematology.

Prediction of HER2 gene status in Her2 2+ invasive breast cancer: a study of 108 cases comparing ASCO/CAP and FDA recommendations

Gaëtan MacGrogan, F. Chibon, V. Brouste, 2009, Modern Pathology.

Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: A multivariate analysis of the French Sarcoma Group database.

J. Blay, F. Collin, V. Brouste, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diagnostic accuracy of breast MRI for patients with suspicious nipple discharge and negative mammography and ultrasound: a prospective study

V. Brouste, F. Chamming's, J. Chopier, 2021, European Radiology.

Smooth muscle differentiation identifies two classes of poorly differentiated pleomorphic sarcomas with distinct outcome

F. Chibon, Gaëlle Pérot, V. Brouste, 2014, Modern Pathology.

Integrative assessment of expression and prognostic value of PDL1, IDO, and kynurenine in 371 primary soft tissue sarcomas with genomic complexity.

J. Blay, V. Brouste, O. Mir, 2016 .

Pulsed-dose-rate brachytherapy for uterine cervix carcinoma: 10 years of experience with 226 patients at a single institution.

F. Guyon, V. Brouste, A. Floquet, 2013, Brachytherapy.

Assessment of risk factors for occurrence or worsening of acetabular fracture following percutaneous cementoplasty of acetabulum malignancies.

X. Buy, V. Brouste, A. Crombé, 2019, European journal of radiology.

Joint frailty models for recurring events and death using maximum penalized likelihood estimation: application on cancer events.

Virginie Rondeau, Hélène Jacqmin-Gadda, Simone Mathoulin-Pelissier, 2006 .

[Adjuvant radiation therapy for soft tissue sarcoma of the extremities: analysis of local control according to volume and dose].

V. Brouste, B. Bui, G. Kantor, 2005, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Predictive factors of depressive symptoms of elderly patients with cancer receiving first‐line chemotherapy

V. Brouste, S. Mathoulin-Pélissier, M. Rainfray, 2017, Psycho-oncology.

Combined Ablation and Resection (CARe) as an Effective Parenchymal Sparing Treatment for Extensive Colorectal Liver Metastases

V. Brouste, S. Mathoulin-Pélissier, M. D'Angelica, 2014, PloS one.

Patterns of complications following intraoperative radiofrequency ablation for liver metastases.

V. Brouste, P. McKelvie-Sebileau, S. Evrard, 2014, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Impact of immunohistochemical markers, CK5/6 and E‐cadherin on diagnostic agreement in non‐invasive proliferative breast lesions

A. Vincent-Salomon, V. Brouste, I. de Mascarel, 2008, Histopathology.

Multivariate frailty models for two types of recurrent events with a dependent terminal event: Application to breast cancer data

Virginie Rondeau, Simone Mathoulin-Pélissier, Yassin Mazroui, 2013, Biometrical journal. Biometrische Zeitschrift.

Predictors of early death risk in older patients treated with first-line chemotherapy for cancer.

A. Ravaud, V. Brouste, A. Floquet, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Local and Metastatic Relapse Features in Patients After a Primary Soft Tissue Sarcoma: Advocating for a Better-Tailored Follow-Up

V. Brouste, M. Toulmonde, A. Italiano, 2019, Front. Oncol..

Expression of neurotensin receptor-1 (NTS1) in primary breast tumors, cellular distribution, and association with clinical and biological factors

E. Hindié, V. Brouste, G. MacGrogan, 2021, Breast Cancer Research and Treatment.

Radiofrequency ablation as a substitute for surgery in elderly patients with nonresected breast cancer: pilot study with long-term outcomes.

V. Brouste, S. Mathoulin-Pélissier, L. Mauriac, 2012, Radiology.

Triple-negative breast cancers: associations between imaging and pathological findings for triple-negative tumors compared with hormone receptor-positive/human epidermal growth factor receptor-2-negative breast cancers.

V. Brouste, G. MacGrogan, S. Mathoulin-Pélissier, 2013, The oncologist.

Radiological features of triple-negative breast cancers (73 cases).

V. Brouste, S. Mathoulin-Pélissier, M. Debled, 2012, Diagnostic and interventional imaging.

Ductal Carcinoma In Situ of the Breast: Influence of Age on Diagnostic, Therapeutic, and Prognostic Features. Retrospective Study of 812 Patients

V. Brouste, G. MacGrogan, L. Mauriac, 2011, Annals of Surgical Oncology.

Impact of 18 FDG- PET CT in the Management of Muscle Invasive Bladder Cancer.

V. Brouste, F. Bladou, H. de Clermont-Gallerande, 2022, Clinical genitourinary cancer.

[Prevention of infectious complications after cesarean section by the use of cefotetan].

V. Brouste, J. Leng, E. Janky, 1989, Journal de gynecologie, obstetrique et biologie de la reproduction.

Re: Population-based study of peritumoral lymphovascular invasion and outcome among patients with operable breast cancer.

V. Brouste, I. de Mascarel, G. MacGrogan, 2010, Journal of the National Cancer Institute.

Liver metastases in close contact to hepatic veins ablated under vascular exclusion.

V. Brouste, P. McKelvie-Sebileau, S. Evrard, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study

V. Brouste, O. Chapet, P. Richaud, 2017, PloS one.

Anterior Gradient-2 (AGR2) is overexpressed in colon cancer and is a potential biomarker of microsatellite instability (MSI) tumors

V. Brouste, I. Soubeyran, I. Mahouche, 2022, bioRxiv.

Anterior Gradient-2 (AGR2) overexpression in colon cancer: a potential prognostic biomarker

V. Brouste, I. Soubeyran, I. Mahouche, 2021 .

Early objective response may not be a prognostic factor of survival for patients with metastatic urothelial carcinoma: from a retrospective analysis of a cohort of 113 patients

S. Culine, V. Brouste, P. Pourquier, 2015, Journal of Negative Results in BioMedicine.

Is a one-year follow-up an efficient method for better management of MRI BI-RADS(®) 3 lesions?

V. Brouste, C. Ziadé, S. Ferron, 2016, Breast.

Parenchymal sparing surgery for colorectal liver metastases: The need for a common definition.

V. Brouste, Y. Bécouarn, S. Evrard, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Retrospective analysis of chemotherapy choices and overall survival according to treatment in 96 patients >75 years old with metastatic breast cancer

V. Brouste, L. Mauriac, A. Floquet, 2008 .

Distinction between isolated tumor cells and micrometastases in breast cancer

V. Brouste, I. de Mascarel, G. MacGrogan, 2008, Cancer.

Renal cell carcinoma lung metastases treated by radiofrequency ablation integrated with systemic treatments: over 10 years of experience

A. Ravaud, X. Buy, V. Brouste, 2019, BMC Cancer.

Impact of Obtaining a Digital Breast Tomosynthesis (DBT) Spot Compression View on Assessment of Equivocal DBT Findings.

V. Brouste, I. Thomassin-Naggara, F. Chamming's, 2022, AJR. American journal of roentgenology.

Time-varying coefficients in a multivariate frailty model: Application to breast cancer recurrences of several types and death

Virginie Rondeau, Simone Mathoulin-Pélissier, Audrey Mauguen, 2015, Lifetime Data Analysis.

Clinical, radiological and genetic features, associated with the histopathologic response to neoadjuvant chemotherapy (NAC) and outcomes in locally advanced soft tissue sarcoma (STS) patients (pts).

V. Brouste, C. Lucchesi, J. Coindre, 2017 .

CorrespondenCe re : population-Based study of peritumoral Lymphovascular Invasion and outcome Among patients With operable Breast Cancer

V. Brouste, G. MacGrogan, L. Mauriac, 2022 .

Distal extremities soft tissue sarcomas: Are they so different from other limb localizations?

S. Salas, V. Brouste, P. Terrier, 2019, Journal of surgical oncology.

Impact on survival without chemotherapy of local treatments of lung metastasis of colorectal cancers: Analysis on REPULCO cohort.

X. Buy, V. Brouste, J. Palussiere, 2024, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Is a one-year follow-up an efficient method for better management of MRI BI-RADS(®) 3 lesions?

V. Brouste, C. Ziadé, S. Ferron, 2016, Breast.